FDA Issues New Rules For Pharmaceutical Patent Litigation
The U.S. Food and Drug Administration on Thursday revised and clarified its regulations for the way new drug applications and pharmaceutical patent information is processed in a final rule the organization...To view the full article, register now.
Already a subscriber? Click here to view full article